Skip to content

Breastfeeding and blood Pressure patterns in MOthers with recent hypertensive coMplications of pregnancy - BP-MOM Study

Pilot randomized trial of a nurse-led self-efficacy based breastfeeding intervention in women with hypertensive disorders of pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18352227
Enrollment
75
Registered
2019-01-29
Start date
2019-01-02
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive disorders of pregnancy, including preeclampsia and gestational hypertension Pregnancy and Childbirth

Interventions

Nurse-led breastfeeding enhancing intervention, including a maternal assessment followed by the provision of tailored lactation management strategies to enhance breastfeeding self-efficacy and support

Sponsors

McGill University Health Centre
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Age >18 years 2. Diagnosis of hypertensive disorder of pregnancy (preeclampsia or gestational hypertension) 3. Singleton live birth delivered at >34 weeks gestation 4. Mother intends to breastfeed and breastfeeding initiated before hospital discharge 5. Patient speaks and understands English or French 6. Patient has telephone access

Exclusion criteria

Exclusion criteria: 1. Maternal contraindication to breastfeeding 2. Maternal condition that interferes with breastfeeding 3. Neonatal condition that interferes with breastfeeding 4. Infant born before 34 weeks gestation 5. Maternal ICU admission lasting >24 hours

Design outcomes

Primary

MeasureTime frame
Feasibility, including recruitment, retention and participant satisfaction with the intervention: 1. Recruitment rate is defined as the number of eligible women who consented/number of eligible women who were approached, calculated at baseline 2. Retention rate is defined as the number of women who complete 12-month follow-up for the study/all women who consent to participate, calculated at 12-month follow-up 3. Participant satisfaction with the breastfeeding intervention will be measured using a self-administered questionnaire that includes quantitative and qualitative items on participants' satisfaction with the support received from the study nurse, measured at 3 months and 6 months postpartum

Secondary

MeasureTime frame
1. Exclusive breastfeeding assessed by self-report at 6 months and 12 months postpartum 2. Total breastfeeding duration assessed by self-report at 6 months and 12 months postpartum 3. Blood pressure measured by the study nurse at 12 months postpartum 4. Use of anti-hypertensive medication as ascertained from the participant's medical chart at 12 months postpartum

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026